header logo image


Page 32«..1020..31323334..»

Archive for the ‘Molecular Genetics’ Category

Two Genes May Dictate How Social, Friendly You Are – Laboratory Equipment

Tuesday, August 22nd, 2017

Whether you are a social butterfly or more of a shy homebody may at least in part be attributable to your genes.

A new study by researchers at the National University of Singapore reports that two specific genes play a role in young adults social skills and the number of close friends they have.

The study, published in Psychoneuroendocrinology focused on the CD38 gene and the CD157 gene sequence both of which regulate oxytocin, the human social hormone.

Oxytocin is involved with behaviors such as pair-bonding, mating and child-rearing. It is also linked with more complex emotions and traits like empathy, trust and generosity.

The NUS study included 1,300 Chinese participants living in Singapore. The researchers examined how the expression of CD38 and the sequence changes of CD517 related to the participants social skills.

Their social behaviors were evaluated through questionnaires that asked about participants ability to engage in social relationships, the quality of friendships they have and the value they place on those friendships.

The team found that a higher expression of the CD38 gene and the presence of differences in the CD157 gene sequence correlated with a participant having more close friends and better social skills.

According to study leader Richard Ebstein, professor with NUS Psychology, this study was unique because many other gene studies focus on just structural changes in gene sequences, and how that affects a particular characteristic or disease. But by studying gene expression, Ebstein and fellow researchers were able capture more information than simple structural studies.

The higher expression and changes in the genes accounted for 14 percent of the variance in social skills in the general population. Typically, less than two percent of findings in behavioral genetic association studies rely on genetic variations alone.

The researchers also noted that the results were even more profound in the male participants.

Male participants with the higher gene expressions displayed greater sociality such as preferring activities involving other people over being alone, better communication and empathy-related skills compared to the other participants. Meanwhile, participants with lower CD38 expression reported less social skills such as difficulty in reading between the lines or engaging less in social chitchat, and tend to have fewer friends, said Anne Chong, PhD graduate who conducted the research with Ebstein.

Moreover, while expressed genes can influence behaviors, our own experiences can influence the expression of genes in return. So, whether the genes are expressed to impact our behaviors or not, depend a lot on our social environments. For most people, being in healthy social environments such as having loving and supportive families, friends and colleagues would most likely lessen the effects from disadvantageous genes, added Chong.

Another interesting find the team reported was that a variation in the CD157 gene sequence, which was found to be more common in autism cases in a previous Japanese study, was also associated with the participants innate interest in socializing and building relationships.

Ebstein and Chong believe these results could be useful in developing future intervention therapies or targeted treatments that would help achieve desired results for individuals with special needs. For example, they note that treatments based on new drugs that mimic of enhance the functions of the CD38 and CD157 genes could be one potential approach.

The researchers are now conducting several behavioral economics and molecular genetics studies to investigate the impact of oxytocin on human traits like creativity and openness to exposure.

Here is the original post:
Two Genes May Dictate How Social, Friendly You Are - Laboratory Equipment

Read More...

Sunquest Information Systems Announces the General Availability of Sunquest Mitogen: Molecular LIMS and … – Markets Insider

Tuesday, August 22nd, 2017

TUCSON, Ariz., Aug. 22, 2017 /CNW/ -- Sunquest Information Systems, Inc. announced today the general availability of Sunquest Mitogen, a laboratory information management system (LIMS) and genetic analysis software suite for molecular diagnostics and precision medicine. The comprehensive, integrated molecular and genetics laboratory solution streamlines data and processes across the wet lab and the dry lab from sample accessioning and tracking; to lab workflows, inventory and reagent management; to data generation, genetic analysis, and clinical report creation and delivery.

"Sunquest is committed to advancing technology to allow our laboratory partners to respond to market demand. As medical treatments become more precise, clinicians are looking to laboratories to support precision medicine. This requires taking on complex lab processes and delivering easy-to-understand, clinically actionable reports with short turnaround times and at lower cost," said Matt Hawkins, president/CEO of Sunquest. "The innovation embodied in Sunquest Mitogen makes this much easier."

"We wanted a platform that was paperless, cutting-edge, alive and responsive. But with many LIMS platforms we looked at, attempting to adapt them to molecular testing was like fitting a square peg into a round hole. Sunquest Mitogen is different it is designed for molecular testing," said Dr. Jason Walker, chief scientific officer at MedComp Sciences, a clinical laboratory services company and Sunquest client. "The end result is something we are truly proud of at MedComp. It is an investment we have made in laboratory quality and in our future."

"Sunquest delivers laboratory solutions that support world-class labs," Hawkins added. "Sunquest Mitogen is an innovative, comprehensive and flexible solution for laboratories to simplify and streamline extremely complicated molecular diagnostics and genetic testing processes and analysis. Sunquest Mitogen flexibly fits into existing laboratory workflows and new workflows are quick to build, which is essential in a molecular lab."

Nabil Hafez, senior director of product management for Sunquest's precision medicine solution added, "By taming the extreme complexity of molecular diagnostic laboratory processes and genetic variant analysis, we're creating the right conditions for laboratories to offer these important diagnostic tests."

Sunquest Mitogen laboratory software addresses the high complexity of sample lineage, laboratory processes, and genetic analysis for molecular diagnostics and precision medicine, which requires a laboratory platform designed from its foundation for this kind of laboratory work. In addition, Sunquest Mitogen interfaces with other clinical software, instruments, and services at the lab, and the electronic medical records used by healthcare providers.

The new solution combines the power of two key complimentary acquisitions, GeneInsight and UNIConnect, and optimizes the combined value with a set of pre-defined, out-of-the-box workflows for the LIMS and genetic analysis components.

About Sunquest Information Systems

Sunquest Information Systems Inc. provides diagnostic informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world enhance efficiency, improve patient care, and optimize financial results. Sunquest's solutions enable world-class lab capabilities, including multisite, multi-disciplinary support for complex anatomic, molecular and genetic testing, and engagement with physicians and patients outside the hospitals at the point-of-care.

Headquartered in Tucson, AZ with offices in Boston, London, Dubai, United Arab Emirates, and Bangalore, India, Sunquest is a global leader in healthcare information Technology. For more information, visit http://www.sunquestinfo.com/mitogen

Contact info:Trish MoxamVice President, Corporate Marketingrel="nofollow">trish.moxam@sunquestinfo.com520-237-4024

SOURCE Sunquest Information Systems, Inc.

Visit link:
Sunquest Information Systems Announces the General Availability of Sunquest Mitogen: Molecular LIMS and ... - Markets Insider

Read More...

Duke researchers discover way to increase flu shot effectiveness – Duke Chronicle

Tuesday, August 22nd, 2017

Duke researchers have found a way to speed up the production of flu vaccines and make them more effective against seasonal flu virus strains.

Many vaccine companies grow the influenza virus inside of a chicken egg, where a protein called hemagglutinin, orHA, often mutates and causes the vaccine to lose some of its effectiveness. Researchers developed a new way to prompt the virus to express two copies of the HA protein, one specialized to function in the egg and the other in humans. This would prevent the human HA from adapting to the chicken egg and enhance the effectiveness of the vaccine.

We found that this process is very effective. We can grow the virus with two copies of the HA gene in the chicken egg without it acquiring mutations, said Nicholas Heaton, assistant professor of molecular genetics and microbiology in the School of Medicine.

Heaton explained the two primary reasons behind the flu vaccine's "traditionally low efficacy." First, the World Health Organization must predict which flu strains will be prevalent in humans during flu season. This means that an incorrect selection of strain could lead the vaccine to be ineffective even if properly manufactured.

Second, the practice of taking a human flu virus and growing it in a chicken egg can also generate problems, Heaton said. The virus may undergo mutations within the egg and come out with a mutated HA protein, limiting the vaccine's ability to activate the human immune system.

The idea that taking the human virus and inserting it into a chicken eggan obviously different environmentfor growth is what our research studies, Heaton noted. When the vaccine is administered, people create a strong immune response to what theyve been exposed to, which is a weird egg-adapted version of the human virus."

Heaton and his team's solution to the second part of the problem was to develop the technology that allowed the small genome of thehuman influenza virus to accommodate and express more than one HA gene.

Its very hard to manipulate human influenza viruses. To insert another hemagglutinin protein grows the genomes size by about 20 percent," Heaton said. "The methodology of doing so wasnt well known in the field."

There is a lot to be done moving forward before the technology can be implemented into seasonal influenza vaccines.

The goal is to now show that on a year-to-year basis, our methodology is doing something. Nobody has had a mechanism to do a side-to-side comparison, Heaton noted. We know that the flu shot produces antibodies within a person that recognize only the chicken egg-grown virus. No one has formally shown how much better the protection would be if all your antibodies were given the correct human virus because there was no way to do so before this technology.

The next step is to generate the mixture of four viruses that are currently in the flu shot. After generating the viruses, Heaton saidthe new technology needs to be implemented.

We will have to quantify how much better the virus grows using our technology, how much better the immune response is and how much more protective it proves to be, he said.

Link:
Duke researchers discover way to increase flu shot effectiveness - Duke Chronicle

Read More...

Study finds that you may be as friendly as your genes – Medical Xpress

Tuesday, August 22nd, 2017

A depiction of the double helical structure of DNA. Its four coding units (A, T, C, G) are color-coded in pink, orange, purple and yellow. Credit: NHGRI

A group of researchers from the National University of Singapore has found that CD38 and CD157 genes that regulate oxytocin, the supreme human social hormone, are associated with the sociality of young individuals. They found that young adults who have higher expression of the CD38 gene as well as differences in CD157 gene sequence are friendlier and more socially adept than others. They have more close friends and show greater social skills

Researchers found that CD38 and CD157 genes that regulate oxytocin, the supreme human social hormone, are associated with the sociality of young individuals

Why some individuals seek social engagement and friendship while others shy away may well be dependent on the expression and sequence of two genes in their bodies.

This novel study of gene expression (i.e. how much of a particular gene is produced in the body) supports the increasing importance of the oxytocin network and its impact on shaping social and communication skills that are important for building friendships. The findings were published in the scientific journal Psychoneuroendocrinology.

The study was conducted by Professor Richard Ebstein and recent NUS PhD graduate, Dr Anne Chong, from the Department of Psychology at NUS Faculty of Arts and Social Sciences, along with Professor Chew Soo Hong from the Faculty's Department of Economics and Professor Lai Poh San from the Department of Paediatrics at NUS Yong Loo Lin School of Medicine.

The team studied over 1,300 healthy young Chinese adults in Singapore in a non-clinical setting. They investigated the correlation between the expression of the CD38 gene and CD157 gene sequence, both of which have been implicated in autism studies, and an individual's social skills as captured by three different questionnaires. These questionnaires evaluated the participants' overall ability to engage in social relationships; their value on the importance of and interest in friendships as well as the number of close friends/confidants they have.

Link between CD38 and CD157 genes, oxytocin and social skills

"We believe that studying the expression of genes captures more information than simple structural studies of DNA sequence since it is the expression of genes that ultimately determine how a gene impacts our traits. Oxytocin plays an important role in these behaviours so it made good sense to our team to study the oxytocin network in relation to social skills important for friendships," said Prof Ebstein.

The results from the study showed that participants with higher expression of CD38 have more close friends, and this association was observed more prevalently among the male participants.

"Male participants with the higher gene expressions displayed greater sociality such as preferring activities involving other people over being alone, better communication and empathy-related skills compared to the other participants. Meanwhile, participants with lower CD38 expression reported less social skills such as difficulty in "reading between the lines" or engaging less in social chitchat, and tend to have fewer friends," said Dr Chong who is the first author of the study and worked under the supervision of Prof Ebstein.

Interestingly, the researchers found that a variation in the CD157 gene sequence that was more common in autism cases in a Japanese study, was also associated with the participants' innate interest in socialising and building relationships.

The evidence suggests that oxytocin, and the CD38 and CD157 genes that govern its release, contribute to individual differences in social skills from one extreme of intense social involvement (i.e. many good friendships and good relationships with peers) to the other extreme of avoiding social contacts with other people that is one of the characteristics of autism. There is no cause for worry however, as the researchers note that majority of people are in between the two extremes.

The researchers found that higher expression of the CD38 gene and differences in the CD157 gene sequence account for 14 per cent of the variance in social skills in the general population a remarkable finding, especially since typically less than two per cent of findings in behavioural genetic association studies rely on genetic variations alone.

"Moreover, while expressed genes can influence behaviours, our own experiences can influence the expression of genes in return. So, whether the genes are expressed to impact our behaviours or not, depend a lot on our social environments. For most people, being in healthy social environments such as having loving and supportive families, friends and colleagues would most likely lessen the effects from disadvantageous genes," said Dr Chong.

The findings from the study help deepen the understanding of the relationship between human sociability and oxytocin. By releasing the social hormone, the CD38 and CD157 genes not only regulate social life at a cellular level but also contribute to the development of human social skills important in establishing social bonds and friendship.

"In our study, we see that an individual's genetic makeup could only go so far as predicting one's social predisposition but does not necessarily trigger the trait since, in the end, it is the expression of gene that determines so. This knowledge would be helpful in coming up with future intervention therapies or targeted treatments to achieve desirable outcomes for individuals with special needs," said Prof Ebstein.

For instance, while there is already considerable research interest in using oxytocin therapy to improve the social skills of individuals with autism, the results so far have been mixed. The findings in this study point to an alternative research direction towards treatments based on new drugs that may mimic or enhance the functions of the CD38 and CD157 genes. The researchers noted however that this line of research has yet to be explored. If proven viable, future therapies may help those clinically determined to have extreme difficulty maintaining social and working relationships with others so that they too could live a better quality of life.

Next steps in research

Co-led by Prof Ebstein and Prof Chew, the Behavioural and Biological Economics and the Social Sciences (B2ESS) Group at the NUS Faculty of Arts and Social Sciences has been investigating the role of genes and hormones on human behaviours, decision making, and a variety of human attitudes including empathy, impulsivity, political attitudes, religiosity and risk attitudes.

The group is currently embarking on several behavioural economics and molecular genetics studies to investigate the impact of oxytocin on the human traits of creativity and openness to exposure, among others.

Explore further: Combination approach may boost social interactions in autism

More information: Anne Chong et al. ADP ribosyl-cyclases ( CD38 / CD157 ), social skills and friendship, Psychoneuroendocrinology (2017). DOI: 10.1016/j.psyneuen.2017.01.011

See more here:
Study finds that you may be as friendly as your genes - Medical Xpress

Read More...

Science and Society on the Vineyard – Martha’s Vineyard Times

Tuesday, August 22nd, 2017

Betty Burton is the coordinator of the Adult Lecture Series at the VHPL.

Marthas Vineyard is proud of how it preserves tradition: We cherish life in the slow lane. But this is 2017 and we are part of the modern world, and the latest scientific advancements affect us as much as they do anyone.To explore how science touches all of us in our everyday lives, the Vineyard Haven Public Library, funded in part by a grant from the National Science Foundation, is in the middle of an ambitious summer program on the themes of science and society, science, and everyday life. The grant, administered by a program called Rural Gateways, with the theme of Pushing the Limits, also funds similar programs in 110 other rural libraries. It allows us to participate in a nationwide reading, viewing, and discussion series. Since the beginning of time, humans have imagined and achieved ways to push the boundaries of the physical world.We want to be stronger, smarter, more aware; with great new advances in science and technology, we are finding ways in which all of us are able to push the limits every day. The Pushing the Limits program will explore these ideas in discussions that will include recommended popular books and feature film-quality videos with authors, scientists, and everyday people who thrive on exploring the natural world.Rural Gateways, Pushing the Limits, is funded not only by NSF but also was created through a collaboration of Dartmouth College, the Califa Library Group, the Association of Rural and Small Libraries, Dawson Media Group, and the Institute for Learning Innovation. The speaker series sponsored by this grant will feature programs both this summer and next winter. A science reading group is also meeting on Mondays at 3 pm every three weeks until Sept. 11.Some of the programs so far:Jonathan White presented our very first program, Tides: The Science and Spirit of the Ocean. Mr. White a lifelong mariner traveled the globe for 20 years to examine one of the most primal forces on the planet. The result is a gorgeous exploration of the science, mystery, and history of earths oceanic tides.

In July, Dr. Daniel Goleman presented Altered Traits: Science Reveals How Meditation Transforms Mind, Body, and Brain. Dr. Goleman is an author, psychologist, and science journalist. For 12 years, he wrote for the New York Times, reporting on the brain and behavioral sciences. He is probably best known for his books on emotional intelligence. He has recently written a book with the Dalai Lama, A Force for Good.

On August 10, award-winning science journalist Peter Brannen, presented his new book, The Ends of the World: Volcanic Apocalypses, Lethal Oceans, and our Quest to Understand Earths Past Mass Extinctions. As new, groundbreaking research suggests that climate change played a major role in the most extreme catastrophes in the planets history, Peter took us on a wild ride through the planets five mass extinctions and, in the process, offered us a glimpse of our increasingly dangerous future.

On August 17, Donald Berwick, MD, MPP FRCP, president emeritus and senior fellow, Institute for Healthcare Improvement, and former administrator of the Centers for Medicare and Medicaid Services, spoke about Health Care as it Should Be. A pediatrician, Dr. Berwick has served on the faculty of the Harvard Medical School and Harvard School of Public Health, and on the staff of Bostons Childrens Hospital Medical Center.

On Thursday, August 24, at 7 pm, Dr. Henry Kriegsteins subject will be Digging for Dinosaurs in the Badlands. Dr. Kriegstein will describe his passion for paleontology, organizing private digs in the Dakotas, Wyoming, and Montana, and collecting dinosaur fossils. One fossil, which Dr. Kriegstein bought from a collector in Tucson, turned out to be a completely new, previously undiscovered mini T.rex, now named Raptorex kriegsteini. Every summer, Dr. Kriegstein returns to the Badlands and continues his search for fossils. He considers it a philosophical perspective on the mystery of life and the beauty of the mineral-laced fossils.

On Wednesday, August 30, at 7 pm at the Katharine Cornell Theatre, the library will host a panel CRISPR and Genetic Editing: Uncharted Waters. Leading scientists and bioethicists from Harvard, MIT, Harvard Kennedy School, Stanford and the Woods Hole Oceanographic Institution will discuss the astounding new techniques that make editing DNA nearly as easy as editing an email (well, that is if you have a degree in molecular genetics). Along with vast potential for curing disease, feeding the world, and eliminating pollution come vexing issues of fairness, safety and morality.

Included on this panel will be Dr. Sheila Jasanoff from Harvards Kennedy School. She is one of the worlds leading bioethicists. Simply put, her job is to think and talk about the ethics of the work being done with gene editing. Professor Kevin Esvelt from the MIT Media Lab is director of the Sculpting Evolution group, which invents new ways to study and influence the evolution of ecosystems. His current project is developing mice that are immune to Lyme disease and releasing them on Nantucket. Professor Neel Aluru, of the Biological Labs at Woods Hole Oceanographic Institution, is in the field of environmental epigenetics, which involves studying how environmental factors interact with DNA, turning genes on or off. WHOI is one of the premiere institutions in the world for this kind of research. Professor Jeantine Lunshof, is an assistant professor at the Department of Genetics, University Medical Center Groningen, the Netherlands, and currently a visiting professor at Harvard. She is a philosopher and bioethicist, based in the synthetic biology laboratory of Dr. George Church. As an embedded ethicist, Dr. Lunshof works with scientists at all stages of their research to help identify potential areas of concern. MV Times science columnist, Professor Emeritus Paul Levine from Stanford, will open with introductory remarks about the short history of genetic engineering from the 70s. John Sundman will moderate the panel. His background includes writing and speaking at various institutions about CRISPR. This presentation is funded in part by a grant from National Science Foundation and Califa Library Groups.

As part of this grant, we have started a Science Book Club. So far we have read When the Killings Done by T. C. Boyle and Thunderstruck by Erik Larson. For each meeting we have viewed interviews by the authors, who discuss their take on the science in their stories. On Monday, August 28, at 3 pm we will discuss Arctic Drift by Clive Cussler. The topic of this section is Survival and how it fits into our worlds of science. On Monday, Sept. 11, at 3 pm we will discuss Land of the Painted Caves by Jean Auel and our subject will be Knowledge.

The series will continue into 2018 with more books and speakers to come.

Im happy to say that getting this grant has prompted me to re-establish our connection to the Woods Hole Marine Biological Lab and the Woods Hole Oceanographic Institution, both world-class research institutions that you can almost see with the naked eye from Vineyard Haven.

This series has special importance to me. Long before moving to the Vineyard I was a research scientist in molecular biology labs in Indiana, North Carolina, and Boston. A lot of the work I did was pure research on viral DNA, with no immediate real-world impact. But in North Carolina I was part of a research team that worked on a vaccine for Haemophilus influenza Type B. Before the vaccine, it was the leading cause of meningitis and other invasive bacterial diseases among children younger than 5. But my biggest thrill came when I was a graduate student. I was invited to present my research at Cold Spring Harbor Laboratory in 1978. That was the mecca for all DNA researchers then. I was in the middle of giving my talk when I looked up and saw Francis Crick at the back of the room, standing next to James Watson [geneticists who won the Nobel Prize for solving the structure of DNA], both of them looking right at me. I nearly fainted.

For more information and schedules in one place, visit vhlibrary.org.

Here is the original post:
Science and Society on the Vineyard - Martha's Vineyard Times

Read More...

Should scientists be on social media? Meet the groundbreaking Saudi researcher who thinks so – Arab News

Monday, August 21st, 2017

DUBAI: Nouf Al-Numair, a jet-setting young scientist from Riyadh, is working tirelessly to encourage Saudi youths to take an interest in science, technology, engineering and math (STEM).She could be the perfect role model for those who wish to make a name for themselves in the field, especially considering her call for lab-bound scientists to get out there and show off their achievements on social media.She obtained an MSc and a Ph.D. in bioinformatics and molecular genetics from University College London (UCL).Despite still being in her early 30s, she now works as a bioinformatics and molecular genetics scientist at King Faisal Specialist Hospital and Research Center.She is also an assistant professor at the College of Medicine at Alfaisal University, and is engaged in volunteer work.After pursuing her undergraduate studies in Saudi Arabia, Al-Numair headed to the UK. After my internship at King Faisal Specialist Hospital and Research Center, I spent time rotating between different labs, she told Arab News.It was then that I realized I wanted to explore how two different scientific fields the pathology of molecular genetics and the technology of computer science could merge. At the time of my placement, this approach wasnt available at universities and hospitals in Saudi Arabia.But the fashionable scientist, with perfectly-coiffed hair and a chic abaya, insists the move was about so much more than just her academic dreams.Going abroad and studying there, living there and exposing myself to a different education will enrich me as a person, she said.Everyone can access knowledge on the Internet, in books but the experience itself is one of the main reasons.Al-Numair is especially grateful to her family for supporting her desire to pursue her dream. When a family sees potential, they should really take care of it and polish it to convert this interest into a real thing, she said.But young aspiring innovators who do not have family support should still follow their passions, as it is up to the individual to make it work, she added. I wasnt taught this dream or passion, I practiced it.Al-Numair is now one of the first Saudi scientists to major in molecular genetics and programing biological information, a precise science that enables practitioners to read the future of diseases before they come into existence through genetic mutation.She uses more than seven programing languages to analyze human genes. She has published several papers and has spoken at multiple international conferences.Since I was young, I always thought of myself as a creator, an innovator. Even then, I wanted to be a pioneer of an interesting field, she said.In 2014, Al-Numair was honored by the Saudi ambassador to the UK in a ceremony celebrating outstanding students for their scientific achievements.She decided to return to the Kingdom to pursue a career in STEM as Saudi Arabia is my birth country. Who does not want to return home?In the Kingdom, she works tirelessly to encourage interest in the science and technology sector. Im a member of the MiSK youth community (the Prince Mohammed bin Salman bin Abdul Aziz Foundation). MiSK focuses on the countrys youth and provides different means of fostering talent, creative potential and innovation that paves the way toward opportunities in the arts and sciences, she said, calling on more young people especially women to take part.I hope that more Saudi and Arab women will join the field. This is why Im participating in the #Championofscience campaign and developing videos with the British Council. Were doing this because we believe its important to shed more light on stories of incredible women working in STEM, to inspire the next generation of girls to become leading scientists.British Councils across the Gulf are working to highlight Arab women working in STEM who are making a real difference in terms of research and innovation in their countries.The council invited participants, including Al-Numair, to film a short video explaining why they chose to follow their dreams, in a bid to encourage young people to show an interest in STEM.Writing is good as you can express yourself, but a video, even if its only one minute youre speaking the language of the young generation, and with social media its crazy now, Al-Numair said of the campaign.We as scientists should be out there more. We should use social media and put ourselves out there and express ourselves. Why not use Snapchat just to picture my daily stuff like the labs and students? This lets the young generation understand that its a joy, because sometimes they stereotype science as boring, but its really not. If you really love what youre doing, youll enjoy it, she said.I believe its time for the media to put these achievements in the spotlight, and for scientists to use the power of social media to reach larger audiences and inspire future generations.

DUBAI: Nouf Al-Numair, a jet-setting young scientist from Riyadh, is working tirelessly to encourage Saudi youths to take an interest in science, technology, engineering and math (STEM).She could be the perfect role model for those who wish to make a name for themselves in the field, especially considering her call for lab-bound scientists to get out there and show off their achievements on social media.She obtained an MSc and a Ph.D. in bioinformatics and molecular genetics from University College London (UCL).Despite still being in her early 30s, she now works as a bioinformatics and molecular genetics scientist at King Faisal Specialist Hospital and Research Center.She is also an assistant professor at the College of Medicine at Alfaisal University, and is engaged in volunteer work.After pursuing her undergraduate studies in Saudi Arabia, Al-Numair headed to the UK. After my internship at King Faisal Specialist Hospital and Research Center, I spent time rotating between different labs, she told Arab News.It was then that I realized I wanted to explore how two different scientific fields the pathology of molecular genetics and the technology of computer science could merge. At the time of my placement, this approach wasnt available at universities and hospitals in Saudi Arabia.But the fashionable scientist, with perfectly-coiffed hair and a chic abaya, insists the move was about so much more than just her academic dreams.Going abroad and studying there, living there and exposing myself to a different education will enrich me as a person, she said.Everyone can access knowledge on the Internet, in books but the experience itself is one of the main reasons.Al-Numair is especially grateful to her family for supporting her desire to pursue her dream. When a family sees potential, they should really take care of it and polish it to convert this interest into a real thing, she said.But young aspiring innovators who do not have family support should still follow their passions, as it is up to the individual to make it work, she added. I wasnt taught this dream or passion, I practiced it.Al-Numair is now one of the first Saudi scientists to major in molecular genetics and programing biological information, a precise science that enables practitioners to read the future of diseases before they come into existence through genetic mutation.She uses more than seven programing languages to analyze human genes. She has published several papers and has spoken at multiple international conferences.Since I was young, I always thought of myself as a creator, an innovator. Even then, I wanted to be a pioneer of an interesting field, she said.In 2014, Al-Numair was honored by the Saudi ambassador to the UK in a ceremony celebrating outstanding students for their scientific achievements.She decided to return to the Kingdom to pursue a career in STEM as Saudi Arabia is my birth country. Who does not want to return home?In the Kingdom, she works tirelessly to encourage interest in the science and technology sector. Im a member of the MiSK youth community (the Prince Mohammed bin Salman bin Abdul Aziz Foundation). MiSK focuses on the countrys youth and provides different means of fostering talent, creative potential and innovation that paves the way toward opportunities in the arts and sciences, she said, calling on more young people especially women to take part.I hope that more Saudi and Arab women will join the field. This is why Im participating in the #Championofscience campaign and developing videos with the British Council. Were doing this because we believe its important to shed more light on stories of incredible women working in STEM, to inspire the next generation of girls to become leading scientists.British Councils across the Gulf are working to highlight Arab women working in STEM who are making a real difference in terms of research and innovation in their countries.The council invited participants, including Al-Numair, to film a short video explaining why they chose to follow their dreams, in a bid to encourage young people to show an interest in STEM.Writing is good as you can express yourself, but a video, even if its only one minute youre speaking the language of the young generation, and with social media its crazy now, Al-Numair said of the campaign.We as scientists should be out there more. We should use social media and put ourselves out there and express ourselves. Why not use Snapchat just to picture my daily stuff like the labs and students? This lets the young generation understand that its a joy, because sometimes they stereotype science as boring, but its really not. If you really love what youre doing, youll enjoy it, she said.I believe its time for the media to put these achievements in the spotlight, and for scientists to use the power of social media to reach larger audiences and inspire future generations.

Original post:
Should scientists be on social media? Meet the groundbreaking Saudi researcher who thinks so - Arab News

Read More...

Tea vs coffee – which cuppa should you be drinking? – Telegraph.co.uk

Monday, August 21st, 2017

Best for improving bone strength? Tea

Thanks to caffeines slight blocking effect on calcium absorption, coffee is often mistakenly pilloried as contributing to weakened bone density. (In fact, any such effects of caffeine on calcium absorption is so small, it is fully offset by the tiniest splash of milk.)

Conversely, studies have long linked black tea with improved bone strength but, says MacLennan, the benefits of green tea may be even greater.

He cites research from Texas, published in 2013 in the American Journal of Clinical Nutrition: It found that the epigallocatechin (EGCG) compound, which is abundant in green tea, can decrease the numbers of osteoclasts in the body these are the cells that break down bone and increase the numbers and activity of osteoblasts, the cells that build bone. Green tea may also be helpful if you need to speed up the healing process of a broken bone.

Go here to see the original:
Tea vs coffee - which cuppa should you be drinking? - Telegraph.co.uk

Read More...

If you’re watching the total solar eclipse, don’t forget to wear sunscreen – Yahoo News

Monday, August 21st, 2017

(People use solar film to photograph the first annular eclipse seen in the U.S. since 1994 on May 20, 2012 in Grand Canyon National Park, Arizona.Getty) If you're planning to marvel in the total solar eclipse on August 21, be sure to wear sunscreen especially if you're planning to view itfor a long time.

While you might be more concerned with keeping your eyes safefrom the sun, the hour or two you spend watching the whole process will leave your skin exposed.

"The levels of damaging ultraviolet (UV) light will only be low during the brief, total solar eclipse occurring within the narrow path of totality, in which the sun is completely blocked by the moon," Christin Burd, a Damon Runyon-fundedprofessor molecular genetics at The Ohio State University, told Business Insider in an email. After the totality, "the unblocked UV rays will be intense and could easily result in sunburn," she said.

For the peopleinthe 70-mile-wide streak of the country that will be able to see the total solar eclipse, the buildup to the event will likely take longer than theyexpect, astronomer Amanda Bauer told ScienceAlert.Those who are just popping out for a few minutes to see a partial eclipse, which varies in timing and size across the country, might get away without lathering up.

Here are some otherthings you should bring if you're going to see the total solar eclipse, according to Mark Littman and Fred Espenek, authors of "Totality: The Great American Eclipses of 2017 and 2024."

NOW WATCH: All the nasty things inside a pimple and why you should stop popping them

More From Business Insider

Originally posted here:
If you're watching the total solar eclipse, don't forget to wear sunscreen - Yahoo News

Read More...

Myriad Genetics, Inc. (MYGN) Hits a New 52-Week High – Modern Readers

Monday, August 21st, 2017

Advertisement

The company is trading unchanged by 0.00 percent from yesterdays close. Company shares last traded at $28.80 which is significantly higher than the 50 day moving average which is $25.48 and a great deal higher than the 200 day moving average of $21.36. The 50 day moving average was up $3.32 and the 200 day average went up by +34.86%.

Myriad Genetics, Inc. (Myriad), launched on November 6, 1992, is a molecular diagnostic company. The Company is involved in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individuals risk for developing disease later in life, identify a patients likelihood of responding to drug therapy and guide a patients dosing to enable optimal treatment, or assess a patients risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology..

Here are a few additional firms who have increased or decreased their stake in (MYGN). Bb&t Investment Services, Inc. trimmed its investment by shedding 31 shares a decrease of 1.0% as of 12/31/2016. Bb&t Investment Services, Inc. owns 2,927 shares valued at $49,000. The value of the position overall is down by 14.0%. As of quarter end Advisory Services Network, LLC had disposed of 200 shares trimming its holdings by 11.8%. The value of the companys investment in Myriad Genetics, Inc. increased from $32,000 to $39,000 a change of $7,000 quarter over quarter.

As of the end of the quarter Disciplined Growth Investors Inc /mn had bought a total of 2,335 shares growing its position 0.2%. The value in dollars went from $26,097,000 to $35,182,000 a change of 34.8% since the last quarter. Sterling Capital Management LLC downsized its ownership by selling 32,878 shares a decrease of 1.7%. Sterling Capital Management LLC controls 1,848,772 shares worth $47,772,000. The total value of its holdings increased 32.2%.

On August 18 the company was upgraded from Buy to Hold in a statement from Deutsche Bank. On August 9 Barclays kept the company rating at Equal-Weight but raised the price target from $22.00 to $26.00.

Myriad Genetics, Inc. currently has a P/E ratio of 90.28 and market capitalization is 1.97B. In the last earnings report the EPS was $0.32 and is estimated to be $1.02 for the current year with 68,437,000 shares presently outstanding. Analysts expect next quarters EPS to be $0.25 with next years EPS anticipated to be $1.16.

See original here:
Myriad Genetics, Inc. (MYGN) Hits a New 52-Week High - Modern Readers

Read More...

Science graduate helps to conquer a global problem – Evening Observer

Sunday, August 20th, 2017

Fredonia alumni Nick Catanzaro, 13, with Dr. Deborah Good, 87, at Virginia Tech, having fun celebrating last falls #FREDlanthropy Day.

A Fredonia alumnus, now a graduate student at Virginia Tech, has been awarded a fellowship to investigate a virus responsible for significant economic losses in the swine industry.

Nicholas Catanzaro, of Lewiston, N.Y., completed a bachelors degree in Molecular Genetics at Fredonia in 2013. He first visited Virginia Tech during the summer of 2012 to participate in Research Experiences for Undergraduates, a 10-week summer program that introduced him to microbiology research at the university.

Mr. Catanzaro credited his undergraduate professors at Fredonia with preparing him for the next step in his studies. Through integrative and engaging experiences in both the classroom and lab, I learned valuable skills and techniques that allowed me to hit the ground running upon starting my dissertation research, Catanzaro said. However, it was the environment and culture at Fredonia, especially within the Biology department, that prepared me the most. The people around me, both my peers and professors, made science exciting and motivated me to learn.

Catanzaro, a Ph.D. student in the Virginia Tech Department of Biomedical Sciences and Pathobiology, hopes his research on porcine reproductive and respiratory syndrome virus (PRRSV) will eventually help scientists develop safer, better vaccines. He was recently awarded a two-year, $95,000 fellowship from the U.S. Department of Agricultures National Institute of Food and Agriculture for his research.

This is one of the most economically devastating global swine pathogens and causes more than $600 million in economic losses in the United States alone each year, Catanzaro said. My fellowship looks at how the virus causes disease in pigs. Thats important because scientists are trying to make safer, more-effective vaccines for pigs against the virus.

First discovered in 1987, PRRSV causes reproductive failures in pregnant sows and respiratory disease in young piglets. Although it has similarities to the Coronaviridae family of viruses, which include the deadly severe acute respiratory syndrome (SARS), it cannot spread from animals to humans and poses no food safety threat.

Catanzaros interest in research peaked during his time at Fredonia, he said. During my junior and senior years at Fredonia, I worked on an undergraduate research project with Dr. Theodore Lee, Cantanzaro said. We were interested in microbial communities involved in a unique geological process along the banks of Canadaway Creek. This research experience allowed me to apply the skills and techniques discussed in the classroom to a real world problem. In working with Dr. Lee, I realized research was something I enjoyed and would like to pursue as a career.

Thanks to his Fredonia undergraduate degree, Catanzaro is able to do just that.

Reprinted in part with permission from Virginia Tech University.

The Northern Chautauqua Community Foundation is offering a Grant Writing Workshop on Oct. 10 from 9 to 11 a.m. This ...

SILVER CREEK Two sessions of the five-hour pre-licensing course will be offered by the Community Education ...

Oct. 19-22Unless otherwise noted, reservations for events may be made at: http://alumni.fredonia.edu/Events.aspx. ...

Originally posted here:
Science graduate helps to conquer a global problem - Evening Observer

Read More...

Dr Tom: Why I believe in vaccinations – Stuff.co.nz

Sunday, August 20th, 2017

TOM MULHOLLAND

Last updated05:00, August 20 2017

123RF

If I had a belief that vaccination was harmful, I wouldn't vaccinate my kids or myself.

Belief is an interesting thing. It is the cause of much of the conflict in the world, our communities, and in our own homes. It can seriously affect our wellbeing. Current conflict of beliefs sees war, fatal riots in the US, and political resignations and resurrections in our own land.

Beliefs are layered down and they become more deeply entrenched through a process known as the Ladder of Inference. Beliefs can cause actions or inactions, such as vaccinating or not vaccinating yourselves or your children.

For years, I believed vaccination was relatively safe and prevented terrible diseases. I vaccinated myself, my children and thousands of patients in my medical practices. The belief was based on what I had learnt in getting a FirstClass Honours degree in molecular genetics, a further five years of study to get my medical degree then about 10 years' clinical experience as a doctor.

READ MORE:*Dr Cathy Stephenson: Vaccinations are part of a 'bigger picture'*Vaxxed: A view from both sides of the debate*To frame anti-vaccine rhetoric as 'debate' is dangerous and wrong

So, my belief was seriously challenged with news that vaccination could potentially be linked to autism. I felt sick. I couldn't sleep. I became a doctor to help people, not harm them, myself or my own children. Contrary to some beliefs, we don't become doctors to work for pharmaceutical companies and we are not rewarded by them with perks and overseas travel.

So how could this be? I needed to know more what research was out there to suggest or prove a link with vaccination and autism. My enquiry over 10 years ago showed there was no link and in 2010 the original study was discredited and the author criticised for serious misconduct.

Proper studies of 500,000 Danish children, 27,000 Canadian children and Japanese children have shown no link with vaccination and autism. To my medical and scientific brain there is no link: vaccination is safe while not vaccinating is unsafe and dangerous. As I write this article, there are reports of vaccinations rates being below 60 per centin some areas, and diseases like polio are making a return.

If I had a belief that vaccination was harmful, I wouldn't vaccinate my kids or myself. Whilewriting this article I did a Google search on vaccination and autism. One site listed a number of scientific papers supporting the argument. Now, reading scientific papers is hard work even for someone who has spent their life doing so. The terms and names of compounds and cellular processes are confusing and hard to make sense of. But whatI could make sense of, was that the articles had nothing to do with vaccination and autism together but definitions of cellular pathways unrelated to either entity.

So, this strengthens thebelief that, as a scientist, as a father and as a doctor, vaccination is not only safe, but vital for our health and wellbeing, both as individuals and as communities.

My belief is also that we should debate the issue not the characters of the people who have conflicting beliefs. Some people have a belief in a sentinel being in the sky, in a god or gods they have never seen. To try and argue otherwise can be frustrating for both sides. If their beliefs don't create actions that impede others wellbeing, they are both entitled to them.

It's when a belief causes harm to others and especially unprotected infants who don't yet have beliefs that the debate can get heated.

The key is education without judgement. In simple terms, play the ball and not the individual, understand their beliefs and re-examine your own, whatever they may be.

Dr Tom Mulholland is an Emergency Department doctor and GP with more than 25 years' experience in New Zealand. He's currently on a mission, tackling health missions around the world.

-Stuff

Read more from the original source:
Dr Tom: Why I believe in vaccinations - Stuff.co.nz

Read More...

Myriad Genetics’ EndoPredict Gets Positive Coverage Decision – Zacks.com

Sunday, August 20th, 2017

Molecular diagnostics and personalized medicine major Myriad Genetics, Inc. (MYGN - Free Report) achieved another milestone as its EndoPredict test got positive coverage decision from Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies.

Notably, EndoPredict is Myriad Genetics next-generation, multigene prognostic test for breast cancer.The test provides information to help doctors devise personalized treatment plans.

Following the full implementation of these decisions, Myriad Genetics will have coverage for over 90% of breast cancer patients post implementation of these decisions.

Considering that EndoPredict has been used clinically in more than 15,000 patients, we areconfident about the growing adaptability of this test post the Medicare coverage approval.

As per a report provided by GBI Research, the global breast cancer treatment market will reach a worth of $17.2 billion by 2021, at a CAGR of 7.3%. Thus, the company clearly has bountiful prospects in this market.

Also, we note that the company has recently received extended Medicare coverage for its Prolasis test.

In this regard we note that, for the past three months, Myriad Genetics has been trading above the broader industry. The stock has gained 32.2%, higher than the industrys gain of 4.5%.

Recent Developments

Myriad Genetics announced that its BRACAnalysis CDxcompanion diagnostic test successfully identifiedBRCA-mutated patients with HER2- metastatic breast cancer in the OlympiAD trial who responded better to treatment with olaparib than standard chemotherapy.

Also, Myriad Genetics presented favorable findings from its BRACAnalysis CDx test which successfully identified patients with metastatic breast cancer in Phase 3 OlympiAD Study.

Zacks Rank & Key Picks

Myriad Genetics carries a Zacks Rank #3 (Hold). A few better-ranked medical stocks are IDEXX Laboratories, Inc. (IDXX - Free Report), Lantheus Holdings, Inc. (LNTH - Free Report) and Align Technology, Inc. (ALGN - Free Report). Align Technology sports a Zacks Rank #1 (Strong Buy), while Lantheus Holdings and IDEXX Laboratories carry a Zacks Rank #2 (Buy). You canseethe complete list of todays Zacks #1 Rank stocks here.

Align Technology has a long-term expected earnings growth rate of 26.6%. The stock has rallied roughly 22.3% over the last three months.

Lantheus Holdings has a long-term expected earnings growth rate of 12.5%. The stock has gained 70.4% over the last six months.

IDEXX Laboratories has a long-term expected earnings growth rate of 19.8%. The stock has gained around 6.8% over the last six months.

4 Surprising Tech Stocks to Keep an Eye on

Tech stocks have been a major force behind the markets record highs, but picking the best ones to buy can be tough. Theres a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now before the next wave of innovations really takes off.

See Stocks Now>>

Read more:
Myriad Genetics' EndoPredict Gets Positive Coverage Decision - Zacks.com

Read More...

Bacteria May Rig Their DNA to Speed Up Evolution – WIRED

Saturday, August 19th, 2017

In 1944, a Columbia University doctoral student in genetics named Evelyn Witkin made a fortuitous mistake. During her first experiment in a laboratory at Cold Spring Harbor, in New York, she accidentally irradiated millions of E. coli with a lethal dose of ultraviolet light. When she returned the following day to check on the samples, they were all deadexcept for one, in which four bacterial cells had survived and continued to grow. Somehow, those cells were resistant to UV radiation. To Witkin, it seemed like a remarkably lucky coincidence that any cells in the culture had emerged with precisely the mutation they needed to surviveso much so that she questioned whether it was a coincidence at all.

Original story reprinted with permission from Quanta Magazine, an editorially independent publication of the Simons Foundation whose mission is to enhance public understanding of science by covering research developments and trends in mathematics and the physical and life sciences.

For the next two decades, Witkin sought to understand how and why these mutants had emerged. Her research led her to what is now known as the SOS response, a DNA repair mechanism that bacteria employ when their genomes are damaged, during which dozens of genes become active and the rate of mutation goes up. Those extra mutations are more often detrimental than beneficial, but they enable adaptations, such as the development of resistance to UV or antibiotics.

The question that has tormented some evolutionary biologists ever since is whether nature favored this arrangement. Is the upsurge in mutations merely a secondary consequence of a repair process inherently prone to error? Or, as some researchers claim, is the increase in the mutation rate itself an evolved adaptation, one that helps bacteria evolve advantageous traits more quickly in stressful environments?

The scientific challenge has not just been to demonstrate convincingly that harsh environments cause nonrandom mutations. It has also been to find a plausible mechanism consistent with the rest of molecular biology that could make lucky mutations more likely. Waves of studies in bacteria and more complex organisms have sought those answers for decades.

The latest and perhaps best answerfor explaining some kinds of mutations, anywayhas emerged from studies of yeast, as reported in June in PLOS Biology. A team led by Jonathan Houseley, a specialist in molecular biology and genetics at the Babraham Institute in Cambridge, proposed a mechanism that drives more mutation specifically in regions of the yeast genome where it could be most adaptive.

Its a totally new way that the environment can have an impact on the genome to allow adaptation in response to need. It is one of the most directed processes weve seen yet, said Philip Hastings, professor of molecular and human genetics at Baylor College of Medicine, who was not involved in the Houseley groups experiments. Other scientists contacted for this story also praised the work, though most cautioned that much about the controversial idea was still speculative and needed more support.

Rather than asking very broad questions like are mutations always random? I wanted to take a more mechanistic approach, Houseley said. He and his colleagues directed their attention to a specific kind of mutation called copy number variation. DNA often contains multiple copies of extended sequences of base pairs or even whole genes. The exact number can vary among individuals because, when cells are duplicating their DNA before cell division, certain mistakes can insert or delete copies of gene sequences. In humans, for instance, 5 to 10 percent of the genome shows copy number variation from person to personand some of these variations have been linked to cancer, diabetes, autism and a host of genetic disorders. Houseley suspected that in at least some cases, this variation in the number of gene copies might be a response to stresses or hazards in the environment.

Jonathan Houseley leads a team that studies genome change at the Babraham Institute in Cambridge. Based on their studies of yeast, they recently proposed a mechanism that would increase the odds for adaptive mutations in genes that are actively responding to environmental challenges.

Jon Houseley/QUANTA MAGAZINE

In 2015, Houseley and his colleagues described a mechanism by which yeast cells seemed to be driving extra copy number variation in genes associated with ribosomes, the parts of a cell that synthesize proteins. However, they did not prove that this increase was a purposefully adaptive response to a change or constraint in the cellular environment. Nevertheless, to them it seemed that the yeast was making more copies of the ribosomal genes when nutrients were abundant and the demand for making protein might be higher.

Houseley therefore decided to test whether similar mechanisms might act on genes more directly activated by hazardous changes in the environment. In their 2017 paper, he and his team focused on CUP1, a gene that helps yeast resist the toxic effects of environmental copper. They found that when yeast was exposed to copper, the variation in the number of copies of CUP1 in the cells increased. On average, most cells had fewer copies of the gene, but the yeast cells that gained more copiesabout 10 percent of the total population became more resistant to copper and flourished. The small number of cells that did the right thing, Houseley said, were at such an advantage that they were able to outcompete everything else.

But that change did not in itself mean much: If the environmental copper was causing mutations, then the change in CUP1 copy number variation might have been no more than a meaningless consequence of the higher mutation rate. To rule out that possibility, the researchers cleverly re-engineered the CUP1 gene so that it would respond to a harmless, nonmutagenic sugar, galactose, instead of copper. When these altered yeast cells were exposed to galactose, the variation in their number of copies of the gene changed, too.

The cells seemed to be directing greater variation to the exact place in their genome where it would be useful. After more work, the researchers identified elements of the biological mechanism behind this phenomenon. It was already known that when cells replicate their DNA, the replication mechanism sometimes stalls. Usually the mechanism can restart and pick up where it left off. When it cant, the cell can go back to the beginning of the replication process, but in doing so, it sometimes accidentally deletes a gene sequence or makes extra copies of it. That is what causes normal copy number variation. But Houseley and his team made the case that a combination of factors makes these copying errors especially likely to hit genes that are actively responding to environmental stresses, which means that they are more likely to show copy number variation.

The key point is that these effects center on genes responding to the environment, and that they could give natural selection extra opportunities to fine-tune which levels of gene expression might be optimal against certain challenges. The results seem to present experimental evidence that a challenging environment could galvanize cells into controlling those genetic changes that would best improve their fitness. They may also seem reminiscent of the outmoded, pre-Darwinian ideas of the French naturalist Jean-Baptiste Lamarck, who believed that organisms evolved by passing their environmentally acquired characteristics along to their offspring. Houseley maintains, however, that this similarity is only superficial.

What we have defined is a mechanism that has arisen entirely through Darwinian selection of random mutations to give a process that stimulates nonrandom mutations at useful sites, Houseley said. It is not Lamarckian adaptation. It just achieves some of the same ends without the problems involved with Lamarckian adaptation.

Ever since 1943, when the microbiologist Salvador Luria and the biophysicist Max Delbrck showed with Nobel prize-winning experiments that mutations in E. coli occur randomly, observations like the bacterial SOS response have made some biologists wonder whether there might be important loopholes to that rule. For example, in a controversial paper published in Nature in 1988, John Cairns of Harvard and his team found that when they placed bacteria that could not digest the milk sugar lactose in an environment where that sugar was the sole food source, the cells soon evolved the ability to convert the lactose into energy. Cairns argued that this result showed that cells had mechanisms to make certain mutations preferentially when they would be beneficial.

Budding yeast (S. cerevisiae) grow as colonies on this agar plate. If certain recent research is correct, a mechanism that helps to repair DNA damage in these cells may also promote more adaptive mutations, which could help the cells to evolve more quickly under harsh circumstances.

Jon Houseley/QUANTA MAGAZINE

Experimental support for that specific idea eventually proved lacking, but some biologists were inspired to become proponents of a broader theory that has come to be known as adaptive mutation. They believe that even if cells cant direct the precise mutation needed in a certain environment, they can adapt by elevating their mutation rate to promote genetic change.

The work of the Houseley team seems to bolster the case for that position. In the yeast mechanism theres not selection for a mechanism that actually says, This is the gene I should mutate to solve the problem, said Patricia Foster, a biologist at Indiana University. It shows that evolution can get speeded up.

Hastings at Baylor agreed, and praised the fact that Houseleys mechanism explains why the extra mutations dont happen throughout the genome. You need to be transcribing a gene for it to happen, he said.

Adaptive mutation theory, however, finds little acceptance among most biologists, and many of them view the original experiments by Cairns and the new ones by Houseley skeptically. They argue that even if higher mutation rates yield adaptations to environmental stress, proving that the higher mutation rates are themselves an adaptation to stress remains difficult to demonstrate convincingly. The interpretation is intuitively attractive, said John Roth, a geneticist and microbiologist at the University of California, Davis, but I dont think its right. I dont believe any of these examples of stress-induced mutagenesis are correct. There may be some other non-obvious explanation for the phenomenon.

I think [Houseleys work] is beautiful and relevant to the adaptive mutation debate, said Paul Sniegowski, a biologist at the University of Pennsylvania. But in the end, it still represents a hypothesis. To validate it more certainly, he added, theyd have to test it in the way an evolutionary biologist wouldby creating a theoretical model and determining whether this adaptive mutability could evolve within a reasonable period, and then by challenging populations of organisms in the lab to evolve a mechanism like this.

Notwithstanding the doubters, Houseley and his team are persevering with their research to understand its relevance to cancer and other biomedical problems. The emergence of chemotherapy-resistant cancers is commonplace and forms a major barrier to curing the disease, Houseley said. He thinks that chemotherapy drugs and other stresses on tumors may encourage malignant cells to mutate further, including mutations for resistance to the drugs. If that resistance is facilitated by the kind of mechanism he explored in his work on yeast, it could very well present a new drug target. Cancer patients might be treated both with normal courses of chemotherapy and with agents that would inhibit the biochemical modifications that make resistance mutations possible.

We are actively working on that, Houseley said, but its still in the early days.

Original story reprinted with permission from Quanta Magazine, an editorially independent publication of the Simons Foundation whose mission is to enhance public understanding of science by covering research developments and trends in mathematics and the physical and life sciences.

See the article here:
Bacteria May Rig Their DNA to Speed Up Evolution - WIRED

Read More...

Science Intrigues Her, Fulfills Her, Propels Her – Patch.com

Saturday, August 19th, 2017

DAVIS, CA -- UC chemist Amelia Amy Ann Rand talks about omega-6 fatty acids as enthusiastically and passionately as nutritionists talk about salmon, broccoli and spinach.

Science intrigues her, fulfills her, and propels her.

Rand, who is drawing widespread recognition for her work with omega-6 fatty acids as a postdoctoral researcher in Bruce Hammock's biological analytical lab at UC Davis, says science is both exciting and rewarding.

Science and chemistry were my two favorite subjects in school, said Rand, who was born in Bermuda but grew up in Nova Scotia, Canada. I had excellent teachers that really fueled my interest. It was their enthusiasm. I remember my eighth grade math teacher leaping up on a table to get her point across about the Pythagorean theorem, and my 11th grade chemistry teacher used memorable metaphors to explain challenging concepts. Both my parents were biologists, and growing up in Eastern Canada we went on many outdoor trips. The combination of motivational teachers and exploring the natural world fueled my interest to continue in science professionally.

Rand thinks of science as a way to connect with the world in many ways, by working to understand it better, collaborating with a network of scientists, and communicating science to the public. Science matters because of its diversity: it heals, transforms, innovates, and understands, all of which globally shape our world.

Rand, who holds a bachelor of science degree in chemistry from Mount Allison University, Canada and a doctorate in environmental chemistry at the University of Toronto, joined the Hammock lab in 2013 and was named a fellow on the Oncogenic Signals and Chromosome Biology T32 Training Grant, Department of Microbiology and Molecular Genetics.

In the Hammock lab, Rand studies omega-6 fatty acids, or technically, the regulation of cancer angiogenesis from the metabolism of epoxy omega-6 fatty acids.

I've thought a lot about translating why my science matters to people outside the field, she said. It helps since what I study is what we eat - the omega-6 fatty acids. While there's much information already informing the public about these fats, there's still so much we don't know about how they affect our health. I talk about the uncertainty and the challenges we still face, and what I'm doing to help fill these gaps.

"Amy took on one of the most demanding projects in the laboratory in asking how a group of natural compounds regulate angiogenesis," said Hammock, a distinguished professor of entomology who holds a joint appointment with the UC Davis Department of Entomology and the UC Davis Comprehensive Cancer Center.

In April of 2016, Rand drew international accolades when she received a prestigious career development award from the American Association for Cancer Researchthe two-year $100,000 Judah Folkman Fellowship for Angiogenesis Research. She won the highly competitive international award for her proposal, Regulation of Cancer Angiogenesis from the Metabolism of Epoxy Omega-6 Fats.

Cancer researchers praised her for her potential as a future leader in the field of angiogenesis research.

We're so proud of her, said Hammock, who directs the campuswide Superfund Research Program, National Institutes of Health Biotechnology Training Program, and the National Institute of Environmental Health Sciences (NIEHS) Combined Analytical Laboratory.

Hammock and Rand collaborate with Harvard Medical School professor Dipak Panigrahy, former researcher in the Hammock lab and a fellow in the late Professor Judah Folkman's angiogenesis research lab. Folkman, the father of angiogenesis research, is best known for pioneering the concept of blocking angiogenesis or the development of blood vessels, to control cancer growth.

"This concept has resulted in a number of anti-cancer drugs and has had a major impact on cancer treament," Hammock said. Of course blood vessel development is also critical for survival."

Looking back, Rand related that her Ph.D research focused on our exposure to fluorinated commercial materials, their resulting metabolism, and how the metabolites might affect our health. While my Ph.D training was heavily focused on analytical chemistry and metabolic characterization, I wanted more formal training on the biological and biochemical mechanisms associated with disease. I've always been interested in research that combines chemistry and biology to enhance our understanding of human health.

Rand encourages students to follow their dreams, to pursue what interests them, if they're able, regardless the subject. I wouldn't be where I am without balancing science with other parts of my life, like performing music during graduate school, which allowed me to come back to the lab with fresh inspiration for next steps. But we need to motivate people, especially minorities, to continue in science, because people from different backgrounds and experiences are necessary for creating a collective mind that does effective scientific research and innovation.

When she started her postdoctoral research, moving across the continent to Davis, she knew few people. Within a short time, I fell into a great community of people at the local climbing gym, that have sparked many outdoor adventures - climbing, backpacking, swimming, and skiing - over the past 3 years. Living in Northern California has been a real treat!

She also has a soft spot for entomology. Growing up, I used to swim insects to shore if I found them floating far from it - I was alarmed to see them nearly drowning, and did my part to help. That might have been what initiated my future role as lifeguard and swimmer.

Hammock says his own long-term interest in nature and biology was fostered by a wonderful scoutmaster who thought kids should be wandering in the woods, and a great biology teacher who provided a microscope to me in high school and said 'go discover.' The move to entomology was further stimulated when I realized that the big cause of human suffering in the world was starvation caused in part by insects eating crops. It was also stimulated by realizing that insect-borne diseases dwarf cancer, heart disease, etc., in terms of human suffering. It is hard to know where science leads.

As for where science leads, Rand has just accepted a position as assistant professor of organic toxicology in the chemistry department, Carleton University in Ontario. She starts her position Sept. 1.

We really hate to lose her, Hammock said, but we're happy for her; this is a really nice position. And, we'll still be collaborating.

"I hope we collaborate for the next 80 years or so," he quipped.

--By Kathy Keatley Garvey, UC Davis Department of Entomology and Nematology

(Photo by Kathy Keatley Garvey)

Get free real-time news alerts from the Davis Patch.

Thanks for your feedback! Now share it with your friends!

Thanks for your feedback.

Originally published August 18, 2017.

Follow this link:
Science Intrigues Her, Fulfills Her, Propels Her - Patch.com

Read More...

First geneticist at IU School of Medicine-Northwest-Gary retires after 32 years – IU Newsroom

Saturday, August 19th, 2017

In 1985, Janice Zunich was hired by Indiana University to fill a medical void in Northwest Indiana.

She is believed to be the region's first geneticist. Before she began her tenure, residents had to travel as far as Chicago or Indianapolis for any type of genetics care. At the time, she said, Indiana was in the midst of moving to a regionalized system to best serve residents. In addition, the administration at IU School of Medicine wanted to bring genetics education to the Northwest campus.

These two factors came together in the "perfect storm" that led to Zunich finding her home at IU School of Medicine-Northwest-Gary, and on Sept. 3 she will retire after 32 years of service.

She is on staff at eight hospitals and serves an area spanning nine counties, so she has spent much of her last 32 years being on-call 24/7.

"This location is the perfect place to put a geneticist, and I have been able to really serve the population," she said.

A bulletin board in her office hallway is covered with photos of infants, children and families whom her work has touched over the years. As a clinical geneticist, Zunich has diagnosed and discovered syndromes; witnessed families lose a baby and then welcome a healthy baby years later; and equipped prospective parents with the information to understand their genetic concerns. All of these families have taken the time to send her a card with photos and thank her for her help.

"Through all of these years, that board is truly the one thing that will bring both tears to my eyes and a smile to my face," she said.

In addition to her placement at the surrounding hospitals, Zunich is a clinical associate professor of medical and molecular genetics at IU School of Medicine-Northwest-Gary.

But she took very seriously her responsibility as the genetics presence in Northwest Indiana, so she also found room to volunteer her time and knowledge to the community. She joined nearly every possible health group, committee and team in the area over the years. Currently, she serves on the breast leadership team and cancer committees of Community Hospital and Methodist Hospital; the board of Mental Health America of Lake County; the advisory board of Lake County's Healthy Families program; the Lake County Child Protection Team; and the Lake County Child Fatality Review Board.

"I wanted to make sure there was a presence for genetic-related conversations, but it was also a wonderful way to give voice to the School of Medicine and represent IU well," she said. "I wanted to show that we were more than just some place on the hill. I wanted to be a part of and provide service to the community."

As someone who holds tremendous passion for her work and who hasn't taken much time to rest since she began her career, Zunich isn't fully hanging up her genetics coat. She is transitioning to part-time work at an area hospital, where she will be focusing on cancer risk assessment.

She thinks she might be ready to give up medicine altogether someday, at which point she dreams of putting her zoology degree to use as a volunteer for the Field Museum in Chicago.

And while she admits she needs a break from the long, on-call hours, she is very thankful for her career at IU and the impact it has allowed her to make.

"I've loved being a member of this community as a representative of the university, the medical school and the genetics specialty," Zunich said.

More:
First geneticist at IU School of Medicine-Northwest-Gary retires after 32 years - IU Newsroom

Read More...

Love of Nature Fuels #DukeTimeOff Photo Winners – Duke Today

Saturday, August 19th, 2017

Audra Ang moved to North Carolina in 2012. Ever since, shes been falling in love with the state and its natural places.

One of the things I really like doing is exploring the area and discovering the things that make it special, said Ang, a senior public relations specialist for University Development.

One day after work this summer, she and a friend visited the Neuse River Greenway Trail in Raleigh and snapped photos of sunflowers around sunset.

We immediatelyfelt the magic of the area, Ang said. It was the golden hour, the sun was setting and there were a ton of people there. It just felt like a great community event.

One of herpictures, below, resulted in Ang winning the grand prize - a night at the JB Duke Hotel - in the 2017 #DukeTimeOff photo campaign.

Angs photo was selected from approximately 430photos shared by Duke staff and faculty, including pictures from six different continents. The 2017 #DukeTimeOff campaign, which ran from May 26 to August 11, highlighted the hobbies, excitement, and big and small summer adventures of University and Health System employees.

The other grand prize photo, below, came from Katie Donahue, a clinical nurse in Duke Health System. Donahue earned dinner for two at the Washington Duke Inn.

Donahue spent part of June visiting a friend in Jackson Hole, Wyoming. She spent a week exploring, hiking, camping and visiting Yellowstone National Park. This picture, taken during a drive back from Grand Teton National Park, captured Donahue on top of a car, soaking in Wyomings wide open spaces.

It was kind of a spur-of-the-moment picture, Donahue said. We were driving back and the road was empty. It was a really pretty view, so we stopped. It was a fun moment.

While pictures were being shared over the summer, a few employees kept popping up. Here are selections from four employees who routinely shared beautiful images of their #DukeTimeOff. As the campaigns most active participants, they each receive a $25 card to Duke University Stores.

Informatics Educator with Duke Health Technology Solutions Michael Palko kept his photographic eye open all summer. But this shot of a quiet beach at Surf City was a favorite.

Among the photos Kara Bonneau, a database analyst with the Center for Child and Family Policy, shared, this one taken during a hike near Blowing Rock was particularly majestic.

Lindsay Gordon-Faranda, a public relations specialist for Duke Childrens Hospital, had a busy summer. This shot from her trip to St. Kitts and Nevis captures the excitement of an adventure about to begin.

Jacqueline Rimmler, a clinical research analyst at Duke Cancer Institute, kept her camera busy during many walks in nature. This picture taken during a hike in Duke Forest illustrates the peace and quiet she found on those outings.

Finally, over the course of the campaign, there were many photos that captured the value of time away from work. Here are 11 that the Working@Duke editorial staff found particularly amazing.

Medical Lab Scientist Jessica Robertson took a trip of a lifetime to Israel in June. She shared this photo of floating in the Dead Sea with her husband. She said it was one of our very favorite memories.

Kathryn Kreider and her husband, Jon, spent part of their time off traveling to Rocky Mountain National Park, where they snapped this photo during a hike that featured this view from 12,000 feet up.

Time off is critical to recharge your mind, body and spirit, she said. It provides perspective and a renewed sense of purpose.

Associate Director of Student Affairs Kyle Fox shared this photo from a trip to Asheville. He and his son enjoyed the pop-up waterpark dubbed Splashville, which comes to life in the summer in the citys Pack Square.

In early June, LeTeya Robinson and her family and friends gathered a Lake Lynn Park in Raleigh to celebrate the birthdays of her son Casey and her husband Kenny.

Time off is important so one can spend time with those who mean the most, she said.

Mike Tuggle, an exercise physiologist at Duke Health and Fitness Center, posted this photo of a day off that began with a run with his doghter.

Took the day off to spend with family, he said.

Critical Care Clinical Pharmacist Morgan Trammel spent part of her summer hiking the remote Faroe Islands. She shared this photo of a spot along the cliffs above Lake Srvgsvatn where she stopped for lunch and enjoyed the view.

The optical illusion is so incredible, but the picture makes the massive cliffs look small, she said.

Samantha Shaltz, a lab research analyst in Dukes Department of Molecular Genetics and Microbiology, and her husband Brad provided one of the campaigns most inventive photos. Taken with a drone, this shot features the pair taking a moment to relax during a June kayak trip to Falls Lake.

Shaltz said the image captures her #DukeTimeOff, which normally consists of crazy kayaking adventures with my husband every weekend in the summer, rain or shine!

Simone Pitre, a program coordinator with the Global Health Innovation Center, visited her sister in Australia earlier this summer. She shared this image of her attempt at zip-lining over the Crystal Cascades Watering Hole near Cairns, Australia.

She wrote that she enjoyed my #DukeTimeOff by trading a cubicle for a waterfall!

Tim Pennigar, a project manager with Duke Health Systems, snapped this photo on July 5 at the border between Alaska and Canadas Yukon Territory. At that point, he was on the home stretch of an epic 11,000-mile motorcycle journey from Durham to Alaska and back.

Personally, hitting the road for a long-distance motorcycle ride creates space for solitude and reflection basically time to work things out while going really fast, he wrote.

Clinical nurse Victoria Yap shared this photo from her July trip to Sunset Beach.

Sun, sand and serenity, my idea of Duke Time off, she wrote.

Natalie King, an embryologist with Duke Fertility, shared this photo during a trip to Grandfather Mountain she took in late June. This photo was taken from the mountain itself, showcasing some of the stunning views of western North Carolina.

Thank you to all Duke staff and faculty who participated this year.

See original here:
Love of Nature Fuels #DukeTimeOff Photo Winners - Duke Today

Read More...

Modern genetic sequencing tools give clearer picture of how corals … – UW Today

Saturday, August 19th, 2017

Environment | News releases | Research | Science

August 16, 2017

The documentary Chasing Coral, released on Netflix in July, is a cinematic warning about how the bleaching of coral reefs may foreshadow how these marine animals will respond to climate change. Corals are key to ocean health because they support the densest, most diverse ecosystems harboring species from turtles to algae to reef fish.

University of Washington scientists are looking at the burgeoning field of coral genetics to better predict, and maybe even prepare for, corals future threats. Their new study uses modern genetic-sequencing tools to reveal the relatedness of three similar-looking corals.

Porites porites can have spindlier branches (upper right) or thicker, knobbier branches (lower images). Scientists have debated whether or not they are the same species.James Dimond/University of Washington

This coral appears to be three different species, but its been debated whether its really three separate species or whether its one thats really variable in its appearance, said first author James Dimond, a UW doctoral student in aquatic and fishery sciences.

Defining a species matters for conservation, because you cant monitor and protect a species if you dont know it exists.

In the past weve relied on physical characteristics, like the coral skeleton, to determine what constitutes a coral species, Dimond said. But the problem with that is that corals can vary their skeletal architecture. So disentangling whether you have two different species or just a single species thats varying itself due to environmental conditions can be really tricky.

Biologists had originally assumed that the widespread Atlantic corals were three species. Then a 2014 genetic study found that they were the same.

The new study, to appear in an upcoming issue of Molecular Ecology, finds new genetic evidence that they may, in fact, be three species. It also provides a glimpse into the epigenetics, a more mysterious form of genetic expression.

Its the most in-depth analysis of coral epigenetics to date, said co-author Steven Roberts, a UW associate professor of aquatic and fishery sciences. It may also prompt a thorough re-evaluation of these corals family trees.

James Dimond snorkeling to collect coral in Belize. He collected 27 coral samples from different environments and with a range of branch thicknesses.Julie Barber

The study examined Porites porites, one of the more common types of corals. It is not among the roughly two dozen coral species listed as endangered. If it were to be listed in the future, biologists would need to know what constitutes a species.

The study used new tools to look at more than 1,000 single-letter changes in the genetic code, a marker of genetic diversity. The previous genetic study had looked at just 10 or 11 of these markers and found them to be the same in all three forms of coral.

It appears to be a matter of looking more deeply into the genome, which is something weve only been able to do for the last couple of years, Dimond said. Molecular biology technology is changing so rapidly, and this is just an example of that.

To definitively conclude that the three forms are, in fact, different species would mean using the same sequencing technique on more samples from across these corals range, which includes the Gulf of Mexico, the Caribbean, the western Atlantic Ocean and off the coast of West Africa.

The authors also looked at epigenetics, which is any process that affects how the genetic code plays out in real life. Dimonds research focuses on the epigenetic process of DNA methylation, in which a carbon-based methyl molecule can bind to the DNA strand and thus affect how it gets translated into a protein that acts in the body.

The studys epigenetic analysis didnt show any consistent pattern among the different coral branch sizes, so was inconclusive. But the authors believe it provides a step forward in understanding this process in corals.

It just gives a glimpse of the epigenetic variation within this group, Dimond said.

Scientists are interested in coral genetics and epigenetics because it could help them predict how corals will adapt to continued changes in the ocean environment.

Coral genetics and epigenetics could also aid in the process of selective breeding, a topic of current interest that could help corals deal with potentially rapid changes in the ocean environment.

Selective breeding involves finding individuals that are more tolerant of high temperatures and, in some cases, finding specific genes that confer resistance to higher temperatures, Dimond said. Once youre identified those genes and identified individuals that have those genes, then you can breed them, and seed reefs with those organisms.

The new study, he said, is part of the fundamental research that could help toward achieving those goals.

The research was funded by a Hall Conservation Genetics Research Award from the UW College of the Environment, the ARCS Foundation Seattle Chapter, the John E. Halver Fellowship to the UW School of Aquatic & Fishery Sciences and the National Science Foundation. The other co-author is Sanoosh Gamblewood at Western Washington University in Bellingham.

###

For more information, contact Dimond at jldimond@uw.edu and 360-650-7400 x253 or Roberts at sr320@uw.edu or 206-866-5141.

NSF Grant: OCE-1559940

Read more:
Modern genetic sequencing tools give clearer picture of how corals ... - UW Today

Read More...

Graduate Molecular Genetics – University of Toronto

Wednesday, August 16th, 2017

The major strength of the Department of Molecular Genetics is its widely recognized Faculty who run a remarkable variety of world-class research programs in diverse areas such as:

Our Faculty have made important contributions in many fields and have been the recipients of numerous national and international awards. As a Department, our major focus is on graduate training. Graduates from our programs regularly gain postdoctoral positions in prestigious laboratories and staff positions in major universities, research institutes and industry throughout the world.

Research in molecular genetics is increasingly driven by technology and the analysis of the systems-level datasets that new technology has enabled. As a result, there is a high demand for researchers who have a solid grounding in quantitative sciences as well as biology. Because few students will have fully achieved this goal as undergraduates, we have developed two Ph.D. ?tracks? within the Molecular Genetics graduate orogram aimed at training this next generation of scientists.

The Quantitative Biology in Molecular Genetics Track (QBMG): This Ph.D. track has been crafted for students who initially specialized in computer science, physics, chemistry, mathematics, statistics, engineering, and other quantitative disciplines as an undergraduate and/or M.Sc student. The QBMG Track will provide quantitative scientists with a foundation in modern biology and mentor them towards leadership in cutting-edge interdisciplinary research.

The Computational Biology in Molecular Genetics Track (CBMG): Computational biology is playing an increasingly critical role in molecular genetics. The CBMG Ph.D. track will provide students who have been primarily trained in biology, but also have an aptitude for quantitative science, with an immersive computational biology curriculum, and leadership in the new discipline of computational molecular genetics.

Members of the department participate in two interdepartmental collaborative graduate programs that provide students with the opportunity to benefit from the wealth of expertise in the University of Toronto community in areas of research that span the boundaries between traditional departments. More information on each of these programs can be found on their web sites:

For a list of Faculty members participating in these collaborative programs see here.

Continue reading here:
Graduate Molecular Genetics - University of Toronto

Read More...

Scientists Have Pinpointed A Method To Make The Flu Vaccine More Effective – Simplemost

Wednesday, August 16th, 2017

If youve ever gotten a nasty case of the flu even though you dutifully got a flu shot, you know that the vaccine is not 100 percent effective. Now, scientists believe that they have devised a new way of producing the vaccine that will offer better protection.

Part of the reason the vaccine is not fully effective is because the strains mutate. For decades, vaccine manufacturers have used chicken eggs to grow the flu virus strains used in the shot. Problems arise when the human strains mutate to adapt to their new environment, making the vaccine an imperfect match for the virus.

Researchers at Duke University have found a way to prevent the strains from mutating, which allows them to make a perfect match for the virus. Their findings have been published in the journal mBio.

We have solved a fundamental problem that scientists had accepted would be part of vaccine productionthat the virus is always going to mutate if it is grown in eggs, said senior study author Nicholas S. Heaton, Ph.D., assistant professor of molecular genetics and microbiology at Duke University School of Medicine. This research could lead to a significantly cheaper and more efficacious vaccine.

Getty Images | Tim Boyle

Despite the flu vaccines current efficacy rate, its probably still in your best interest to get one. According to theCDC Foundation,flu illness costs the U.S. more than $87 billion annually, which includes an estimated $10.4 billion in direct medical expenses.

And if its the needle thats preventing you from getting a flu shot, theres another new development in the world of the flu vaccine that might interest you. A version of a flu vaccine patch developed by Georgia Techs Laboratory for Drug Delivery showed promising results in its first human clinical trial, according to a study in The Lancet, which would make getting vaccinated as easy as slapping on a band-aid.

[h/t: Science Daily]

Originally posted here:
Scientists Have Pinpointed A Method To Make The Flu Vaccine More Effective - Simplemost

Read More...

Cancer Genetics, Inc. to Host Conference Call to Discuss Strategic and Business Rationale of vivoPharm Acquisition – GlobeNewswire (press release)

Wednesday, August 16th, 2017

RUTHERFORD, N.J. and LOS ANGELES, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (The Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced todaythat it will host an investor and analyst call and webcast onTuesday,August 22, 2017at8:30 am Eastern. CGI willdiscuss the strategy and business rationale of the recent transformative and accretive acquisition ofvivoPharm.

CGIs acquisition ofvivoPharm, announced on August 14, 2017,will significantly strengthenthe Company's position as a leader for oncology discoveryand early phase clinical development and testing for biotechnology and pharmaceutical companies. With over a decade of experience in delivering a wide range of discovery and preclinical services to support drug development, target validation and biomarker analysis,vivoPharm has supported over 200 IND submissions for innovative therapies, with a significant focus on immuno-oncology.

Hosted by CGI's CEO and President, Mr. Panna Sharma, the call will introduceinvestors and analysts tonew members of the CGI team, including Dr. RalfBrandt, former CEO and Managing Director ofvivoPharm, who now serves as the President of Discovery & Early Development Services at CGI.

Mr. Sharma will also provide insight into both operational and customer synergies that will result from the integration ofvivoPharm, as well as the long-term strategy for growth. Additional details will also be provided onvivoPharms specialized tumor and disease models, toxicology and pharmacology services, biomarker analysis and animal imaging capabilitiesthat are expected toprovide CGInewopportunities to deepen its relationships with existing biopharma customers through additional discovery and downstream molecular work,while bolstering the Companys previously announced initiative aimed at early-phase drug repurposing and drug rescue programs.

The call details are noted in the table below.

ABOUT CANCER GENETICSCancer Genetics, Inc. is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. We have established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.

The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State.

For more information, please visit or follow us:Internet:www.cancergenetics.comTwitter:@Cancer GeneticsFacebook:www.facebook.com/CancerGenetics

Forward Looking Statements:This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, future growth in revenues, margins, research, technology, clinical development and potential opportunities for Cancer Genetics, Inc. tests and services, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements.

Any statements that are not historical fact (including, but not limited to, statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, risks of cancellation of customer contracts or discontinuance of trials, risks that anticipated benefits from acquisitions will not be realized, uncertainty in the results of clinical trials or regulatory approvals, need and ability to obtain future capital, maintenance of intellectual property rights and other risks discussed in the Cancer Genetics, Inc. Form 10-K for the year ended December 31, 2016 along with other filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Cancer Genetics, Inc. disclaims any obligation to update these forward-looking statements.

Read this article:
Cancer Genetics, Inc. to Host Conference Call to Discuss Strategic and Business Rationale of vivoPharm Acquisition - GlobeNewswire (press release)

Read More...

Page 32«..1020..31323334..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick